Key facts
- Transfar Capital is a other based in Hangzhou, Zhejiang with 4 tracked portfolio companies.
- Notable positions include Meimiao New Materials, Biyo Pharma, LingyiMed, Santo Therapeutics.
About Transfar Capital
Transfar Capital is a corporation based in Hangzhou, China. Established in 1995, the firm operates across multiple sectors, including business services, scientific research and technical services, and finance. The assets are managed by the executive management team.
Free account
See the whole book
- ·Watchlist + alerts for Transfar Capital's activity
Create free account
No card required
Portfolio, priced
4 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Meimiao New Materials | — | $35.1M | — | |
| Biyo Pharma | — | — | — | |
| LingyiMed | — | — | — | |
| Santo Therapeutics | — | — | — |
Frequently asked
- What companies does Transfar Capital invest in?
- Transfar Capital has 4 recorded portfolio companies, including Meimiao New Materials, Biyo Pharma, LingyiMed, Santo Therapeutics.